Skip to main content

Table 3 Rates of surgery in both groups

From: Comparison of efficacy of different route of administration of chemotherapy on unresectable, advanced gastric cancer

  FLEEOX, n = 48 XELOX, n = 37
R0, n (%) 36 (75.0) 17 (45.9)
R1, n (%) 4 (8.3) 1 (2.7)
R2, n (%) 1 (2.1) 3 (8.1)
Inoperable, n (%) 7 (14.5) 16 (43.3)
Refused surgery, n (%) 1 (2.1) 0 (0)
  1. FLEEOX, fluorouracil, leucovorin, epirubicin, epotoside and oxaliplatin; XELOX. capecitabine plus oxaliplatin.